Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia flag Australia · Delayed Price · Currency is AUD
5.97
-0.09 (-1.49%)
Nov 21, 2024, 4:10 PM AEST

Clarity Pharmaceuticals Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Jun '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2018
Net Income
-42.32-42.32-24.6-23.75-10.22-6.95
Upgrade
Depreciation & Amortization
0.150.150.10.050.020.02
Upgrade
Loss (Gain) From Sale of Assets
00--00
Upgrade
Stock-Based Compensation
4.174.171.258.772.071.19
Upgrade
Other Operating Activities
---0--
Upgrade
Change in Accounts Receivable
-2.63-2.63-3.34-3.29-0.71-0.92
Upgrade
Change in Accounts Payable
0.260.260.025.011.07-0.25
Upgrade
Change in Unearned Revenue
----0.08-0.03-0.04
Upgrade
Change in Other Net Operating Assets
-2.87-2.87-0.92-0.010.130.12
Upgrade
Operating Cash Flow
-43.24-43.24-27.5-13.31-7.68-6.83
Upgrade
Capital Expenditures
-0.5-0.5-0.05-0.21-0.06-0.01
Upgrade
Investment in Securities
-54.8-54.83.2-26.5-9.5-
Upgrade
Investing Cash Flow
-55.31-55.313.15-26.71-9.56-0.01
Upgrade
Issuance of Common Stock
121.86121.860.2492.5321.14.7
Upgrade
Other Financing Activities
-6.65-6.65-0.01-5.6-0.683.51
Upgrade
Financing Cash Flow
115.21115.210.2386.9320.418.22
Upgrade
Foreign Exchange Rate Adjustments
0.020.02-0.01-0-00
Upgrade
Net Cash Flow
16.6916.69-24.1246.93.171.37
Upgrade
Free Cash Flow
-43.74-43.74-27.55-13.53-7.74-6.84
Upgrade
Free Cash Flow Margin
-380.14%-380.14%-281.07%-209.43%-242.06%-245.44%
Upgrade
Free Cash Flow Per Share
-0.16-0.16-0.11-0.05-0.04-0.05
Upgrade
Cash Interest Paid
----00.01
Upgrade
Cash Income Tax Paid
0.080.080.10.02--
Upgrade
Levered Free Cash Flow
-29.52-29.52-19.59-7.23-3.9-4.3
Upgrade
Unlevered Free Cash Flow
-29.52-29.52-19.59-7.23-3.9-4.3
Upgrade
Change in Net Working Capital
5.355.354.41-1.61-0.521.08
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.